VivoSeq
Other

Joint

0

Pipeline Programs↗

10

Active Trials↗

5

Companies Involved↗

Joint is an early-stage landscape with 0 programs across 5 companies. The most active players are Takeda, Novo Nordisk, Theodoros Mylonas.

Intelligence

Pipeline Metrics

Competitive Density

27/100

Pipeline Velocity

25/100

Mech. Concentration

N/A

Completion Rate

82/100

Attrition Rate

8/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Takeda logo

Takeda

0 programs

PreclinicalNovo Nordisk logo

Novo Nordisk

0 programs

PreclinicalT

Theodoros Mylonas

0 programs

PreclinicalE

Everwell Health

0 programs

PreclinicalR

Restor3D

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

25

clinical trials

Completed9 · 36%
Unknown status4 · 16%
Active, not recruiting4 · 16%
Recruiting3 · 12%
Not yet recruiting3 · 12%
Terminated2 · 8%

Clinical Trials

Trial Activity

25 trials

Aromatherapy in Reducing PONV for Total Joint Replacement Patients
Recruiting·HHong Kong Buddhist Hospital·N/A·NCT07281885·159 enrolled
An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct
Recruiting·Novo Nordisk logoNovo Nordisk·N/A·NCT05621746·100 enrolled
Retrospective and Prospective Clinical Outcomes Study of the Zimmer® Nexel™ Total Elbow
Recruiting·ZZimmer Biomet·Preclinical·NCT02469662·134 enrolled
Effect of Chromium on Blood Sugar After Sacroiliac Joint Injection
Active, not recruiting·FFayoum University·Phase 4·NCT06709313·60 enrolled
A Study Assessing the Safety of Cord Blood Product in Sacroiliac Joint Syndrome (SIJ)
Active, not recruiting·UUniversity of Florida·Phase 1·NCT06415461·9 enrolled
Evaluation of Using Patient Specific Ultra-High Molecular Weight Polyethylene Implant Versus Patient Specific Titanium Implant in Treatment of Chronic Condylar Dislocation A Randomized Control Trial
Active, not recruiting·CCairo University·Preclinical·NCT07698678·20 enrolled
Prospective, Multi-center Study to Evaluate the Safety and Effectiveness of the OR3O™ Dual Mobility System in Primary and Revision Total Hip Arthroplasty (THA) Procedures
Active, not recruiting·SSmith & Nephew, Inc.·N/A·NCT04325022·177 enrolled
A Randomized, Triple-blind, Placebo Controlled, Parallel Clinical Trial to Investigate the Efficacy and Safety of a Plant-derived Cetylated Fatty Acids (CFA) on Knee Pain and Stiffness in Healthy Adults With Persistent Knee Pain
Not yet recruiting·EEverwell Health·Preclinical·NCT07695714·80 enrolled
The restor3d Outcomes Registry: Tracking Patient Recovery After Joint Replacement
Not yet recruiting·RRestor3D·N/A·NCT07563803·2,000 enrolled
Reliability and Reproducibility of Pathria Scale-Based Grading of Facet Joint Degeneration and Facet Joint Morphometric Measurements in the Thoracolumbar Spine
Not yet recruiting·SSklifosovsky Institute of Emergency Care·N/A·NCT07670039·12 enrolled
Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout
Completed·Takeda logoTakeda·Phase 2·NCT01078389·314 enrolled
Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF
Completed·UUniversity Hospital, Akershus·Phase 4·NCT02647619·80 enrolled
US Guided Sacroiliac Joint Injection
Completed·—·N/A·NCT06684938·100 enrolled
MDMA-assisted Brief Cognitive Behavioral Conjoint Therapy for PTSD
Completed·—·Phase 3·NCT05979844·16 enrolled
Comparing Post-Op Narcotic Usage in Patients Receiving Periarticular Exparel vs. Standard Periarticular Joint Inj
Completed·UUniversity of California, Irvine·Phase 4·NCT02682498·38 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)